407 related articles for article (PubMed ID: 23573307)
21. Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.
Oral O; Unverdi H; Kumcu E; Turkbey D; Dogan S; Hucumenoglu S
Indian J Pathol Microbiol; 2020; 63(4):551-558. PubMed ID: 33154304
[TBL] [Abstract][Full Text] [Related]
22. Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features.
Wang RQ; Fang DC
J Clin Pathol; 2003 May; 56(5):378-84. PubMed ID: 12719460
[TBL] [Abstract][Full Text] [Related]
23. Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?
Molaei M; Mansoori BK; Mashayekhi R; Vahedi M; Pourhoseingholi MA; Fatemi SR; Zali MR
BMC Cancer; 2010 Oct; 10():537. PubMed ID: 20929551
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon.
Chu PG; Weiss LM
Am J Clin Pathol; 2004 Jun; 121(6):884-92. PubMed ID: 15198362
[TBL] [Abstract][Full Text] [Related]
25. MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6.
Pinto-de-Sousa J; Reis CA; David L; Pimenta A; Cardoso-de-Oliveira M
Virchows Arch; 2004 Mar; 444(3):224-30. PubMed ID: 14758553
[TBL] [Abstract][Full Text] [Related]
26. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.
Walsh MD; Clendenning M; Williamson E; Pearson SA; Walters RJ; Nagler B; Packenas D; Win AK; Hopper JL; Jenkins MA; Haydon AM; Rosty C; English DR; Giles GG; McGuckin MA; Young JP; Buchanan DD
Mod Pathol; 2013 Dec; 26(12):1642-56. PubMed ID: 23807779
[TBL] [Abstract][Full Text] [Related]
27. Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.
Murakami H; Nakanishi H; Tanaka H; Ito S; Misawa K; Ito Y; Ikehara Y; Kondo E; Kodera Y
Gastric Cancer; 2013 Jan; 16(1):74-83. PubMed ID: 22450770
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical study of MUC1, MUC2 and MUC5AC in colorectal carcinoma and review of literature.
Kesari MV; Gaopande VL; Joshi AR; Babanagare SV; Gogate BP; Khadilkar AV
Indian J Gastroenterol; 2015 Jan; 34(1):63-7. PubMed ID: 25731647
[TBL] [Abstract][Full Text] [Related]
29. Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium.
Babu SD; Jayanthi V; Devaraj N; Reis CA; Devaraj H
Mol Cancer; 2006 Mar; 5():10. PubMed ID: 16545139
[TBL] [Abstract][Full Text] [Related]
30. MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis.
Khattab AZ; Nasif WA; Lotfy M
Med Oncol; 2011 Dec; 28 Suppl 1():S207-13. PubMed ID: 20878553
[TBL] [Abstract][Full Text] [Related]
31. The differences between the localizations of MUC1, MUC5AC, MUC6 and osteopontin in quail proventriculus and gizzard may be a reflection of functional differences of stomach parts.
Liman N; Alan E; Küçük Bayram G
J Anat; 2010 Jul; 217(1):57-66. PubMed ID: 20492430
[TBL] [Abstract][Full Text] [Related]
32. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.
Rakha EA; Boyce RW; Abd El-Rehim D; Kurien T; Green AR; Paish EC; Robertson JF; Ellis IO
Mod Pathol; 2005 Oct; 18(10):1295-304. PubMed ID: 15976813
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation.
Giorgadze TA; Peterman H; Baloch ZW; Furth EE; Pasha T; Shiina N; Zhang PJ; Gupta PK
Cancer; 2006 Jun; 108(3):186-97. PubMed ID: 16628655
[TBL] [Abstract][Full Text] [Related]
34. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators.
Lee HS; Lee HK; Kim HS; Yang HK; Kim YI; Kim WH
Cancer; 2001 Sep; 92(6):1427-34. PubMed ID: 11745219
[TBL] [Abstract][Full Text] [Related]
35. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
Park SY; Roh SJ; Kim YN; Kim SZ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217
[TBL] [Abstract][Full Text] [Related]
36. Mucin expression in reactive gastropathy: an immunohistochemical analysis.
Mino-Kenudson M; Tomita S; Lauwers GY
Arch Pathol Lab Med; 2007 Jan; 131(1):86-90. PubMed ID: 17227128
[TBL] [Abstract][Full Text] [Related]
37. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas.
Gürbüz Y; Kahlke V; Klöppel G
Virchows Arch; 2002 May; 440(5):505-11. PubMed ID: 12021925
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas.
Reis CA; David L; Carvalho F; Mandel U; de Bolós C; Mirgorodskaya E; Clausen H; Sobrinho-Simões M
J Histochem Cytochem; 2000 Mar; 48(3):377-88. PubMed ID: 10681391
[TBL] [Abstract][Full Text] [Related]
39. Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach.
Teixeira A; David L; Reis CA; Costa J; Sobrinho-Simões M
J Pathol; 2002 May; 197(1):37-43. PubMed ID: 12081201
[TBL] [Abstract][Full Text] [Related]
40. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
Awaya H; Takeshima Y; Yamasaki M; Inai K
Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
